Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 38 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006En bloc excision in malignant tumors of the lacrimal drainage apparatusValenzuela, A.; Selva-Nayagam, D.; McNab, A.; Simon, G.; Sullivan, T.
2006Clinical features and management of tumors affecting the lacrimal drainage apparatusValenzuela, A.; McNab, A.; Selva-Nayagam, D.; O'Donnell, B.; Whitehead, K.; Sullivan, T.
2008Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II studyLe Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M.; Remberger, M.; Dini, G.; Egeler, R.; Bacigalupo, A.; Fibbe, W.; Ringden, O.
2011Apixaban versus Warfarin in patients with atrial fibrillationGranger, C.; Alexander, J.; McMurray, J.; Lopes, R.; Hylek, E.; Hanna, M.; Al-Khalidi, H.; Ansell, J.; Avezum, A.; Atar, D.; Bahit, M.; Diaz, R.; Easton, J.; Ezekowitz, J.; Garcia, D.; Geraldes, M.; Gersh, B.; Golitsyn, S.; Goto, S.; Hermosillo, A.; et al.
2009Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgeryHeath, M.; Kow, L.; Slavotinek, J.; Valentine, R.; Toouli, J.; Thompson, C.
2007Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporineRuss, G.; Jamieson, N.; Oberbauer, R.; Arias, M.; Murgia, C.; Blancho, G.; Sato, R.; Stoeckl, M.; Revicki, D.
2007Impact of Catheter Ablation of the Coronary Sinus on Paroxysmal or Persistent Atrial FibrillationHaissaguerre, M.; Hocini, M.; Takahashi, Y.; O'Neill, M.; Pernat, A.; Sanders, P.; Jonsson, A.; Rotter, M.; Sacher, F.; Rostock, T.; Matsuo, S.; Arantes, L.; Lim, K.; Knecht, S.; Bordachar, P.; Laborderie, J.; Jais, P.; Klein, G.; Clementy, J.
2008A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux diseaseDent, J.; Kahrilas, P.; Hatlebakk, J.; Vakil, N.; Denison, H.; Franzen, S.; Lundborg, P.
2011Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsKantarjian, H.; Giles, F.; Bhalla, K.; Pinilla-Ibarz, J.; Larson, R.; Gattermann, N.; Ottmann, O.; Hochhaus, A.; Radich, J.; Saglio, G.; Hughes, T.; Martinelli, G.; Kim, D.; Shou, Y.; Gallagher, N.; Blakesley, R.; Baccarani, M.; Cortes, J.; le Coutre, P.
2010Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with ImatinibWhite, D.; Dang, P.; Engler, J.; Frede, A.; Osborn, M.; Saunders, V.; Manley, P.; Zrim, S.; Hughes, T.